{"id":"NCT03901092","sponsor":"Avid Radiopharmaceuticals","briefTitle":"A Reader Study to Assess Accuracy and Reliability of Flortaucipir F 18 Positron Emission Tomography (PET) Scan Interpretation","officialTitle":"A Reader Study to Assess Accuracy and Reliability of Flortaucipir F 18 PET Scan Interpretation","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2019-03-26","primaryCompletion":"2019-04-26","completion":"2019-04-26","firstPosted":"2019-04-03","resultsPosted":"2020-08-11","lastUpdate":"2020-09-09"},"enrollment":242,"design":{"allocation":"NA","model":"SINGLE_GROUP","masking":"NONE","primaryPurpose":"DIAGNOSTIC"},"conditions":["Alzheimer Disease"],"interventions":[{"type":"DRUG","name":"flortaucipir F 18","otherNames":["18F-AV-1451","[F-18]T807","LY3191748"]}],"arms":[{"label":"Flortaucipir PET Scan","type":"EXPERIMENTAL"}],"summary":"This study will evaluate the performance of physician readers trained to read flortaucipir-PET (positron emission tomography) scans.","primaryOutcome":{"measure":"Primary Objective 1 Analysis 1: Diagnostic Performance of Individual Readers (NFT Score)","timeFrame":"baseline scan","effectByArm":[{"arm":"Sensitivity of Flortaucipir vs Autopsy NFT Score","deltaMin":91.5,"sd":null},{"arm":"Specificity of Flortaucipir vs Autopsy NFT Score","deltaMin":77.1,"sd":null}],"pValues":[]},"eligibility":{"minAge":null,"sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":1,"countries":["United States"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":0},"commonTop":[]}}